लोड हो रहा है...

Combination Treatment with Hepatitis C Virus Protease and NS5A Inhibitors Is Effective against Recombinant Genotype 1a, 2a, and 3a Viruses

With the development of directly acting antivirals, hepatitis C virus (HCV) therapy entered a new era. However, rapid selection of resistance mutations necessitates combination therapy. To study combination therapy in infectious culture systems, we aimed at developing HCV semi-full-length (semi-FL)...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Gottwein, Judith M., Jensen, Sanne B., Li, Yi-Ping, Ghanem, Lubna, Scheel, Troels K. H., Serre, Stéphanie B. N., Mikkelsen, Lotte, Bukh, Jens
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society for Microbiology 2013
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3591891/
https://ncbi.nlm.nih.gov/pubmed/23274664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02164-12
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!